Gene · 7003
Papers2,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 2,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma. | Int J Gen Med | 2021 | 34737608 | PubTator, text mining | PubMed |
| Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients. | Clin Epigenetics | 2021 | 34732244 | PubTator, text mining | PubMed |
| Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3. | Acta Pharm Sin B | 2021 | 34729310 | PubTator, text mining | PubMed |
| EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1. | Commun Biol | 2021 | 34725466 | PubTator, text mining | PubMed |
| Enhanced chromatin accessibility contributes to X chromosome dosage compensation in mammals. | Genome Biol | 2021 | 34724962 | PubTator, text mining | PubMed |
| Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway. | Virol J | 2021 | 34717661 | PubTator, text mining | PubMed |
| Paraspeckle Protein NONO Promotes TAZ Phase Separation in the Nucleus to Drive the Oncogenic Transcriptional Program. | Adv Sci (Weinh) | 2021 | 34716691 | PubTator, text mining | PubMed |
| miR-125a-5p promotes gastric cancer growth and invasion by regulating the Hippo pathway. | J Clin Lab Anal | 2021 | 34708891 | PubTator, text mining | PubMed |
| Bioactive components and mechanisms of poplar propolis in inhibiting proliferation of human hepatocellular carcinoma HepG2 cells. | Biomed Pharmacother | 2021 | 34700230 | PubTator, text mining | PubMed |
| Emerging Role of Neuropilin-1 and Angiotensin-Converting Enzyme-2 in Renal Carcinoma-Associated COVID-19 Pathogenesis. | Infect Dis Rep | 2021 | 34698182 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated genome editing directed by a 5S rRNA-tRNAGly hybrid promoter in the thermophilic filamentous fungus Humicola insolens. | Biotechnol Biofuels | 2021 | 34688310 | PubTator, text mining | PubMed |
| Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma. | Mol Cell | 2021 | 34687603 | PubTator, text mining | PubMed |
| Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine. | Cells | 2021 | 34685695 | PubTator, text mining | PubMed |
| Circulating miR-185-5p as a Potential Biomarker for Arrhythmogenic Right Ventricular Cardiomyopathy. | Cells | 2021 | 34685557 | PubTator, text mining | PubMed |
| Yuxiensis granularis gen. et sp. nov., a Novel Quellkörper-Bearing Fungal Taxon Added to Scortechiniaceae and Inclusion of Parasympodiellaceae in Coronophorales Based on Phylogenetic Evidence. | Life (Basel) | 2021 | 34685383 | PubTator, text mining | PubMed |
| Morphology and Phylogeny of Gnomoniopsis (Gnomoniaceae, Diaporthales) from Fagaceae Leaves in China. | J Fungi (Basel) | 2021 | 34682214 | PubTator, text mining | PubMed |
| Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma. | Genes (Basel) | 2021 | 34680895 | PubTator, text mining | PubMed |
| The Role of Hippo/YAP Signaling in Alveolar Repair and Pulmonary Fibrosis. | Front Med (Lausanne) | 2021 | 34671628 | PubTator, text mining | PubMed |
| TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination. | Cancer Cell Int | 2021 | 34663310 | PubTator, text mining | PubMed |
| Regulation of NANOG and SOX2 expression by activin A and a canonical WNT agonist in bovine embryonic stem cells and blastocysts. | Biol Open | 2021 | 34643229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7003/papers?page=50